GBM has asked the SA government to accelerate the evaluation and registration of more affordable biosimilar medicines in South Africa.
All posts tagged 'SAHPRA'
Mental Health Portfolio Manager for Pharma Dynamics, Shouqat Mugjenker, explains why NHI should be implemented with caution.
Government has signed the Medicines and Related Substances Amendment Act (2008) marking the official existence of the much-anticipated SAHPRA.
The CEO and Principal Officer at Profmed explains how the new medical device regulations will significantly change the existing regulatory regime.
The National Department of Health (NDoH) has delayed the launch of the much-anticipated South African Health Products Regulatory Agency (SAHPRA).
CEO of Pharma Dynamics, Erik Roos, explains that as generic penetration intensifies, more growth in the sector can be expected in the coming year.